Breast cancer is a common manifestation of an underlying genetic susceptibility to cancer, and 5% to 10% of all breast cancers are associated with a germline mutation in a known risk allele.
The 2013 Nursing Program: Advancing Oncology Nursing™ webinar series will provide the oncology nurse with comprehensive and clinically relevant information regarding the management of patients with cancer.
Decisions regarding adjuvant chemotherapy for patients with estrogen receptor (ER)–positive HER2-negative lymph node–negative breast cancer have traditionally relied on clinical and pathologic parameters.
The Oncotype DX, PAM50, and MammaPrint are multigene tests that are being used clinically for early-stage breast cancer to predict recurrence risk and guide adjuvant chemotherapy decisions.
This recorded webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Breast and Ovarian Cancer, collectively known as Women’s Health Cancers.
This recorded webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Breast and Ovarian Cancer, collectively known as Women’s Health Cancers.
This recorded webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Breast and Ovarian Cancer, collectively known as Women’s Health Cancers.
This recorded webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Breast and Ovarian Cancer, collectively known as Women’s Health Cancers.
This recorded webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Breast and Ovarian Cancer, collectively known as Women’s Health Cancers.
Facebook
X
LinkedIn
Forward
